[ad_1]
European leaders agreed to establish a trillion euro emergency fund without resolving divisive details on April 23.
The indices of different stock markets in the world have fallen this April 24 after the EU extended a consensus on the details of the incentive package that it will establish to minimize the economic impact that the covid-19 pandemic will have and the doubts regarding progress in the development of vaccines against the new coronavirus, reports the Reuters agency.
The All Country World Index The MSCI, which reflects values from 49 countries, has decreased by 0.3% and it could have its worst week of the last three, while its broadest index for the area Asia Pacific outside from Japan has lost a 0.9%.
On the other hand, European values have decreased by 0.3% and have highlighted the poor results of the FTSE 100 from London who has left a 0.6% after learning that in the UK there was a collapse in retail trade last month.
EU leaders agreed on April 23 to establish an emergency fund for a trillion euros to help the economies of its member countries mitigate the effects of the covid-19 pandemic, but they postponed the resolution regarding its mode of operation.
In this regard, the President of France, Emmanuel Macron, stated that the differences of opinion between the EU countries focused on whether this initiative will consist of community grants or loans.
The indices S&P 500 and Nasdaq They ended negative after the session of the New York Stock Exchange ended on April 23, after a study confirmed that the antiviral drug remdesivir, developed by Gilead Sciences, did not help severe patients with covid-19 in a first series of clinic testsHowever, the pharmaceutical company questioned that result, noting that China ended its investigation too soon.
Stock market sensitivity to news about the treatment of this disease reflected the investor despair for finding clues as to when the global economy will begin its recovery, as “any bad news can alter the market”, considers Tim Ghriskey, chief investment strategist at New York-based Inverness Counsel.
